At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
POAI Predictive Oncology
Not Yet Opened 12-20 16:00:00 EST
0.6896
-0.0274
-3.82%
盘后0.6687
-0.0209-3.03%
19:43 EST
High0.7100
Low0.6800
Vol20.64K
Open0.7100
D1 Closing0.7170
Amplitude4.18%
Mkt Cap4.60M
Tradable Cap4.52M
Total Shares6.67M
T/O14.44K
T/O Rate0.31%
Tradable Shares6.56M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Predictive Oncology engaged in ‘productive discussions’ with multiple parties
Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of optimal cancer therapies. It operates through three segments: Pittsburgh, Birmingham, and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of approximately 150,000 tumor samples and creates proprietary 3D culture models used in drug development. The Birmingham segment offers contract services and research focused on solubility improvements, stability studies, and protein production. The Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Pittsburgh, Pennsylvania.